vs
凌云逻辑（CRUS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是凌云逻辑的1.1倍（$622.0M vs $580.6M），Royalty Pharma plc净利率更高（34.4% vs 24.2%，领先10.3%），Royalty Pharma plc同比增速更快（4.8% vs 4.5%），过去两年凌云逻辑的营收复合增速更高（25.0% vs 4.6%）
凌云逻辑（Cirrus Logic）是美国无晶圆厂半导体供应商，专注于模拟、混合信号及音频数字信号处理集成电路的研发与供应，1998年起总部设立于得克萨斯州奥斯汀市，产品广泛应用于消费电子、智能音频等多个领域。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CRUS vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.1倍
$580.6M
营收增速更快
RPRX
高出0.3%
4.5%
净利率更高
RPRX
高出10.3%
24.2%
两年增速更快
CRUS
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $580.6M | $622.0M |
| 净利润 | $140.3M | $214.2M |
| 毛利率 | 53.1% | — |
| 营业利润率 | 26.3% | 62.4% |
| 净利率 | 24.2% | 34.4% |
| 营收同比 | 4.5% | 4.8% |
| 净利润同比 | 21.0% | 2.9% |
| 每股收益（稀释后） | $2.66 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRUSRPRX
| Q4 25 | $580.6M | $622.0M | ||
| Q3 25 | $561.0M | $609.3M | ||
| Q2 25 | $407.3M | $578.7M | ||
| Q1 25 | $424.5M | $568.2M | ||
| Q4 24 | $555.7M | $593.6M | ||
| Q3 24 | $541.9M | $564.7M | ||
| Q2 24 | $374.0M | $537.3M | ||
| Q1 24 | $371.8M | $568.0M |
净利润CRUSRPRX
| Q4 25 | $140.3M | $214.2M | ||
| Q3 25 | $131.6M | $288.2M | ||
| Q2 25 | $60.7M | $30.2M | ||
| Q1 25 | $71.3M | $238.3M | ||
| Q4 24 | $116.0M | $208.2M | ||
| Q3 24 | $102.1M | $544.0M | ||
| Q2 24 | $42.1M | $102.0M | ||
| Q1 24 | $44.8M | $4.8M |
毛利率CRUSRPRX
| Q4 25 | 53.1% | — | ||
| Q3 25 | 52.5% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.4% | — | ||
| Q4 24 | 53.6% | — | ||
| Q3 24 | 52.2% | — | ||
| Q2 24 | 50.5% | — | ||
| Q1 24 | 51.8% | — |
营业利润率CRUSRPRX
| Q4 25 | 26.3% | 62.4% | ||
| Q3 25 | 25.8% | 70.1% | ||
| Q2 25 | 17.8% | 36.3% | ||
| Q1 25 | 20.2% | 94.0% | ||
| Q4 24 | 26.2% | 60.9% | ||
| Q3 24 | 24.3% | — | ||
| Q2 24 | 12.5% | 50.2% | ||
| Q1 24 | 14.1% | -13.0% |
净利率CRUSRPRX
| Q4 25 | 24.2% | 34.4% | ||
| Q3 25 | 23.5% | 47.3% | ||
| Q2 25 | 14.9% | 5.2% | ||
| Q1 25 | 16.8% | 41.9% | ||
| Q4 24 | 20.9% | 35.1% | ||
| Q3 24 | 18.8% | 96.3% | ||
| Q2 24 | 11.3% | 19.0% | ||
| Q1 24 | 12.1% | 0.8% |
每股收益（稀释后）CRUSRPRX
| Q4 25 | $2.66 | $0.49 | ||
| Q3 25 | $2.48 | $0.67 | ||
| Q2 25 | $1.14 | $0.07 | ||
| Q1 25 | $1.30 | $0.55 | ||
| Q4 24 | $2.11 | $0.46 | ||
| Q3 24 | $1.83 | $1.21 | ||
| Q2 24 | $0.76 | $0.23 | ||
| Q1 24 | $0.78 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $778.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.1B | $9.7B |
| 总资产 | $2.5B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CRUSRPRX
| Q4 25 | $778.1M | $618.7M | ||
| Q3 25 | $593.5M | $938.9M | ||
| Q2 25 | $548.9M | $631.9M | ||
| Q1 25 | $539.6M | $1.1B | ||
| Q4 24 | $526.4M | $929.0M | ||
| Q3 24 | $445.8M | $950.1M | ||
| Q2 24 | $491.4M | $1.8B | ||
| Q1 24 | $502.8M | $843.0M |
总债务CRUSRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益CRUSRPRX
| Q4 25 | $2.1B | $9.7B | ||
| Q3 25 | $2.0B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $1.9B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $1.9B | $10.3B | ||
| Q2 24 | $1.8B | $9.8B | ||
| Q1 24 | $1.8B | $9.9B |
总资产CRUSRPRX
| Q4 25 | $2.5B | $19.6B | ||
| Q3 25 | $2.4B | $19.3B | ||
| Q2 25 | $2.3B | $18.3B | ||
| Q1 25 | $2.3B | $17.6B | ||
| Q4 24 | $2.4B | $18.2B | ||
| Q3 24 | $2.4B | $18.0B | ||
| Q2 24 | $2.3B | $17.7B | ||
| Q1 24 | $2.2B | $16.1B |
负债/权益比CRUSRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $290.8M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $285.7M | — |
| 自由现金流率自由现金流/营收 | 49.2% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 2.07× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $614.5M | — |
8季度趋势，按日历期对齐
经营现金流CRUSRPRX
| Q4 25 | $290.8M | $827.1M | ||
| Q3 25 | $92.2M | $702.6M | ||
| Q2 25 | $116.1M | $364.0M | ||
| Q1 25 | $130.4M | $596.1M | ||
| Q4 24 | $218.6M | $742.5M | ||
| Q3 24 | $8.2M | $703.6M | ||
| Q2 24 | $87.2M | $658.2M | ||
| Q1 24 | $170.5M | $664.6M |
自由现金流CRUSRPRX
| Q4 25 | $285.7M | — | ||
| Q3 25 | $88.3M | — | ||
| Q2 25 | $113.5M | — | ||
| Q1 25 | $127.0M | — | ||
| Q4 24 | $211.9M | — | ||
| Q3 24 | $5.6M | — | ||
| Q2 24 | $77.2M | — | ||
| Q1 24 | $163.5M | — |
自由现金流率CRUSRPRX
| Q4 25 | 49.2% | — | ||
| Q3 25 | 15.7% | — | ||
| Q2 25 | 27.9% | — | ||
| Q1 25 | 29.9% | — | ||
| Q4 24 | 38.1% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 20.6% | — | ||
| Q1 24 | 44.0% | — |
资本支出强度CRUSRPRX
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 1.9% | — |
现金转化率CRUSRPRX
| Q4 25 | 2.07× | 3.86× | ||
| Q3 25 | 0.70× | 2.44× | ||
| Q2 25 | 1.91× | 12.06× | ||
| Q1 25 | 1.83× | 2.50× | ||
| Q4 24 | 1.88× | 3.57× | ||
| Q3 24 | 0.08× | 1.29× | ||
| Q2 24 | 2.07× | 6.45× | ||
| Q1 24 | 3.80× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRUS
| Audio Products Segment | $344.5M | 59% |
| High Performance Mixed Signal Products | $236.2M | 41% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
